The Addition of Temozolomide to Conditioning for Autologous Transplantation in Relapsed & Refractory CNS Lymphoma
Clinical trial NCT01235793 · TERMINATED
Trial details
- NCT number
- NCT01235793
- Sponsor
- Cedars-Sinai Medical Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-14
- Primary completion
- 2017-07-28
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.